ACRBP exhibits a broad expression pattern in several cancers, including ovarian, lung (NSCLC), breast, bladder, colon and liver, and high expression of ACRBP is associated with a poor clinical outcome in ovarian cancer patients with reduced survival time and faster relapse [81,121]. This evidence concerns the gene ACRBP and ovarian cancer.